A Weill Cornell study reveals how disrupted stress-hormone rhythms cause a distinct form of obesity in mice, explaining why timing matters for metabolism.
On September 8, 2026, the journal Cell Reports published new findings from Weill Cornell Medicine researchers regarding how stress hormones influence body weight. The preclinical study demonstrated that disrupting the daily rhythm of glucocorticoids produced an obesity phenotype in mice that differed metabolically from diet-induced obesity. The study was led by Mary Teruel alongside co-first authors Agnieszka Agas and Sanjeev Sharma. Their team successfully separated the physical effects of a high-fat diet from the biological timing of hormone signals.
The central scientific message from the publication is that obesity is not necessarily a single metabolic condition. The tissue distribution of insulin resistance may depend heavily on whether excess weight is driven primarily by diet, hormone timing, or another biological factor. In Teruel’s words, the medical community should “stop treating obesity as one thing” and should also stop treating insulin resistance as one uniform disorder. By examining how daily hormone rhythms interact with nutrition, the researchers provided a biological framework for why metabolic health involves much more than food volume alone.
Glucocorticoids are a class of stress hormones that include cortisol in humans. In normal mice, glucocorticoid levels fall during the rest period and naturally rise near the beginning of the active period. The Weill Cornell Medicine team deliberately flattened this pattern in laboratory mice. They achieved this by raising the normally low hormone level during the rest period and blunting the daily peak, all without substantially increasing average glucocorticoid exposure over time.
To isolate exactly what drives metabolic changes, the researchers independently varied glucocorticoid rhythms and diet to create four distinct experimental groups. The mice received either a normal or a flattened hormone rhythm, and they ate either a standard or a high-fat diet. After 30 days of observation, mice eating a high-fat diet increased their fat mass by about threefold. Meanwhile, mice with flattened glucocorticoid rhythms that remained on a standard diet accumulated about 2.5 times the control level of fat. The researchers described the effects of diet and flattened hormone rhythms as largely additive, meaning the combination produced the greatest overall fat accumulation.
The physical changes extended beyond simple fat storage. The flattened-rhythm mice lost lean muscle mass during the first week, although their lean mass subsequently stabilized and began to increase as the study progressed. This early lean-mass fluctuation is highly relevant to sustainable weight management. It suggests that body-weight gain or loss cannot be accurately interpreted from a basic bathroom scale, as fat mass and lean mass often move differently under different metabolic conditions.
Crucially, both the high-fat-diet mice and the flattened-rhythm mice developed insulin resistance, but the affected tissues differed entirely. In the flattened-rhythm group, insulin resistance was highly concentrated in skeletal muscle. At the same time, their adipose tissue retained a strong insulin response that naturally suppresses fat release. These flattened-rhythm mice also developed dramatically elevated insulin levels. High insulin likely helped keep lipids safely stored in adipose tissue rather than allowing them to accumulate in the liver. This left their livers largely protected from the pathological fat buildup typically seen in high-fat-diet-fed mice.
This recent publication directly builds on an earlier 2022 Cell Reports study from the exact same laboratory. That older study found that flattened glucocorticoid rhythms caused substantial fat accumulation without increased food intake, while blood glucose remained normal and liver fat remained relatively limited. The new 2026 work was specifically designed to explain how that unusual metabolic state could manage to persist despite severe obesity.
Mainstream fitness media frequently frames cortisol as a universal enemy, promoting the idea that high stress directly causes a specific type of human obesity. However, the data from this study presents a much more precise biological reality. The Weill Cornell experiment altered the timing and pattern of glucocorticoid exposure without substantially raising the average hormone levels in the animals. Therefore, the findings should not be summarized as simple proof that sustained high cortisol alone causes obesity. The study tested disrupted timing and flattened rhythmicity, which is a very different biological mechanism.
Teruel noted that the findings raised the possibility that two different mechanisms can make mice obese. She added that the exact same hormone and diet distinction may be occurring in people as well. However, that statement represents a research hypothesis rather than concrete evidence that the precise mouse phenotype has been demonstrated in living humans. While Teruel specifically identified sleep deprivation and chronic stress as possible human factors, the actual study provides no human participant data.
The practical interpretation of these results must remain cautious. The study does support investigating stress-hormone timing as a potential contributor to metabolic dysfunction, but it does not establish a cortisol-based diagnosis for human obesity. The Weill Cornell study was conducted entirely in mice, and mouse glucocorticoid rhythms are organized around a nocturnal active period. Translating the timing of this experimental manipulation directly to human daytime schedules would be medically inappropriate.
Furthermore, the fact that the livers of the flattened-rhythm mice appeared protected should not be interpreted as evidence that the animals were metabolically healthy. They still suffered from severe obesity, intense skeletal-muscle insulin resistance, and dramatically elevated blood insulin levels. Preserved adipose insulin signaling may have successfully limited ectopic lipid deposition in the liver, but that does not mean storing more fat in adipose tissue is completely harmless. Adipose tissue simply cannot buffer excess lipids safely and indefinitely.
While the Weill Cornell study focused on laboratory mice, human experimental research provides adjacent context regarding how poor recovery impacts the body. In one randomized crossover study of 14 human participants, just five nights with four hours of time in bed reduced whole-body insulin sensitivity by 25%. Furthermore, peripheral insulin sensitivity dropped by 29%, while hepatic insulin sensitivity did not change significantly. That same human study also reported a 21% increase in cortisol during the sleep restriction phase, alongside measurable increases in other stress-related hormones.
These clinical observations align with a separate randomized crossover study involving 38 healthy women. In that trial, reducing sleep by approximately 1.34 hours per night for six weeks increased fasting insulin and HOMA-IR values. Crucially, these metabolic declines occurred entirely independently of any changes in body fat. This supports the broader idea that recovery duration can affect insulin sensitivity long before measurable changes in body composition ever occur. Understanding this process helps clarify why inadequate rest influences daily metabolic health regardless of caloric intake.
Broader analyses paint a similar picture across different populations. A meta-analysis of randomized controlled trials reported that partial sleep restriction produced an average weight gain of 0.34 kilograms while reducing insulin sensitivity with a standardized mean difference of -0.70. However, the available results include mixed findings across individual studies, meaning sleep should be viewed as one modifiable metabolic factor rather than a universal explanation for weight gain.
Human research also indicates that glucose handling naturally changes across the day and can differ significantly by tissue type. For instance, one study found greater skeletal-muscle insulin sensitivity in the morning but greater hepatic insulin sensitivity in the evening among people without diabetes. This provides broader physiological context for why timing matters, conceptually similar to how meal timing influences daily biological rhythms.
The Weill Cornell study provides a compelling explanation for how hormonal timing influences energy storage, but significant clinical research is required before these findings become standard medical practice. Future human studies must determine if normalizing glucocorticoid rhythms can actively prevent or reverse muscle-specific insulin resistance in adults. Because the current evidence relies on a preclinical mouse model, scientists need controlled human trials to confirm whether identical tissue-specific insulin responses occur in people experiencing chronic stress.
Additionally, the medical community needs robust data to see if behavioral interventions actually move the needle on this specific mechanism. The study does not show that stress-management practices, fixed meal timing or exercise can normalize glucocorticoid rhythms in adults with obesity. While prioritizing consistent sleep routines and adopting proper exercise form for sustainable resistance training remain sensible habits for supporting muscle tissue, they are not proven clinical cures for a flattened cortisol rhythm.
Finally, researchers must investigate how these timing mechanisms intersect with traditional dietary advice. Teruel suggested the results show “it’s not just how many calories they were eating,” as hormone signals changed how animals handled calories. This does not invalidate the basic physics of calorie balance, but it indicates that the biological response to energy intake is deeply complex. Moving forward, clinical trials must examine how stress-hormone patterns alter the fundamental way human tissue responds to dietary interventions.
WeightRestart shares research-led guidance on weight loss, metabolism, nutrition, strength, appetite, sleep and recovery. Our goal is to make complex health information clear, practical and useful for people building progress they can maintain.
Learn how to build a weight-management approach around better information, realistic expectations and habits you can keep using.
read the blog
